![]() |
|
|
Department of Cellular and Molecular Physiology, The Pennsylvania State University College of Medicine, Hershey, PA 17033
2To whom correspondence should be addressed at The Pennsylvania State University College of Medicine, Department of Cellular and Molecular Physiology, P.O. Box 850, Hershey, PA 17033. E-mail: jjefferson{at}psu.edu.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: leucine insulin translation initiation protein synthesis skeletal muscle
| INTRODUCTION |
|---|
|
|
|---|
| Leucine stimulates protein synthesis in skeletal muscle |
|---|
|
|
|---|
A number of studies previously indicated that most, and perhaps all, of
the effect of a mixture of the BCAAs on skeletal muscle protein
synthesis may be attributable to leucine alone. Buse and Reid
(1975
) demonstrated that incubating isolated rat
hemidiaphragms in the presence of leucine stimulates the incorporation
of labeled precursors into muscle proteins compared to diaphragms
incubated in the absence of the amino acid. Further, the authors
reported that leucine stimulates protein synthesis as effectively as
does a mixture of all three BCAAs. Additionally, Hong and Layman
(1984
) demonstrated that incubating either soleus or
extensor digitorum longus muscles isolated from food-deprived rats
in KrebsRingerbicarbonate buffer supplemented with leucine enhances
protein synthesis compared to muscles similarly incubated in control
buffer without leucine. In perfused rat hindlimb preparations, leucine
at 10 times fasting plasma concentrations stimulates protein
synthesis in muscle as effectively as does a mixture of all three BCAAs
(Li and Jefferson 1978
). These data indicate that
leucine stimulates protein synthesis in skeletal muscle independent of
the other BCAAs.
Initial attempts to demonstrate that leucine stimulates protein
synthesis in skeletal muscle in vivo were not always successful. Buse
et al. (1979
) showed that intraperitoneal injection of
leucine in combination with glucose and insulin to starved rats
increases the proportion of ribosomes in polysomes in skeletal muscle
compared to rats administered only glucose plus insulin. In contrast,
McNurlan and colleagues (1982
) reported no in vivo
effects after intravenous injection of leucine in 2-dstarved or
protein-deprived rats. Additionally, Funabiki and collaborators
(1992
) observed no alterations in muscle protein
synthesis in either food-deprived or diabetic mice following
intraperitoneal administration of leucine. The reason for the
discrepancy between the in vitro and in vivo evidence remains unclear,
but may be related to differences in study design. Alternatively, based
on data from Buse et al. (1979
), insulin may be required
to facilitate the leucine-mediated stimulation of muscle protein
synthesis in vivo.
| Role of insulin |
|---|
|
|
|---|
These results are initially surprising, because leucine was previously
shown to stimulate insulin secretion (Malaisse 1984
).
However, subsequent studies showed that provision of leucine to
food-deprived rats promotes a transient rise in serum insulin from
15 to 45 min after administration (Anthony, J. C. et al.,
unpublished observations). Circulating insulin concentrations are
maximal 30 min following leucine administration when values are
approximately 75% of freely fed rats. Serum insulin returns to
food-deprived control values sometime between 45 and 60 min. This
transient spike in circulating insulin may facilitate the stimulatory
effect of leucine on muscle protein anabolism. Garlick and Grant
(1988
) measured rates of protein synthesis in skeletal
muscle of postabsorptive rats that had been given intravenous infusions
of various combinations of insulin and amino acids. They reported that,
although insulin independently stimulates rates of skeletal muscle
protein synthesis, maximal effects are observed only at circulating
concentrations of the hormone in excess of what is normally seen in
freely fed rats. In contrast, when a complete mixture of amino acids is
coinfused with insulin, maximal rates of protein synthesis are obtained
at insulin concentrations of ~100 pmol/L, well within the
physiological range for food-deprived rats. The results suggest
that leucine independently stimulates protein synthesis in the presence
of fasting or basal concentrations of circulating insulin. Although
these studies indicate necessary contributions of both insulin and
leucine to promote muscle protein anabolism following feeding, the
mechanisms through which these mediators signal for increased rates of
protein synthesis remain to be elucidated.
| Overview of translation initiation |
|---|
|
|
|---|
The initiation of mRNA translation is a complex multistep process
requiring more than a dozen eukaryotic initiation factors (eIFs)
(Pain 1996
, Voorma et al. 1994
). At least
two steps in the initiation pathway are subject to regulation in vivo:
1) binding of initiator methionyl-tRNA
(met-tRNAi) to the 40S ribosomal subunit and
2) binding of mRNA to the 43S preinitiation complex. In the
first step, met-tRNAi binds to the 40S ribosomal
subunit as a ternary complex with eIF2 and GTP. Subsequently, the GTP
bound to eIF2 is hydrolyzed to GDP, and eIF2 is released from the
ribosomal subunit as a complex with GDP. For eIF2 to participate in
another round of initiation, it must exchange GDP for GTP prior to
formation of a new ternary complex. A second initiation factor, eIF2B,
mediates guanine nucleotide exchange on eIF2. Inhibition of eIF2B
activity results in a decrease in the amount of eIF2·GTP available to
form the ternary complex, thereby restraining translation initiation.
eIF2B activity is reciprocally regulated in part by phosphorylation of
eIF2. Phosphorylation of the
-subunit of eIF2 converts eIF2 from a
substrate to a competitive inhibitor of eIF2B (Kimball and Jefferson 1994
).
Another potential rate-controlling step in the process of
translation initiation involves the recognition and unwinding of the
mRNA to allow binding to the 40S ribosome. This step requires a group
of proteins referred to as eIF4F (Fig. 1
). eIF4F is a multisubunit complex consisting of 1) eIF4A, a
RNA helicase that functions in conjunction with another protein, eIF4B
(not shown), to unwind secondary structure in the 5'-untranslated
region of the mRNA; 2) eIF4E, a protein that binds the
m7GTP cap present at the 5'-end of the mRNA; and
3) eIF4G, a large, 220-kDa polypeptide that functions as a
scaffold for eIF4E, eIF4A, the mRNA (via association with eIF4E) and
the ribosome (via association with eIF3; not shown). The eIF4F complex
collectively serves to recognize, unfold and guide the mRNA to the 43S
preinitiation complex (Pain 1996
). One mechanism through
which changes in eIF4F function alter translation initiation involves
modulation of eIF4E availability for binding eIF4G and forming the
active eIF4F complex. The availability of eIF4E for eIF4F complex
formation appears to be regulated by a family of translational
repressors, the eIF4E-binding proteins (4E-BPs) (Pause et al. 1994
). 4E-BP1 competes with eIF4G for binding eIF4E and is able
to sequester eIF4E into an inactive complex. The binding of 4E-BP1 to
eIF4E is regulated by phosphorylation of 4E-BP1, with increased
phosphorylation of the protein causing a decrease in the affinity of
4E-BP1 for eIF4E.
|
| Leucine stimulates translation initiation in skeletal muscle |
|---|
|
|
|---|
are not observed following leucine administration
(Anthony et al. 2000a
In addition to promoting the hyperphosphorylation of 4E-BP1, oral
administration of leucine increases the phosphorylation state of the
70-kDa ribosomal protein S6 kinase (S6K1), particularly at
Thr389, a residue whose phosphorylation is
associated with increased activation of the protein (Burnett et al. 1998
). Increased activity of S6K1 was previously shown to
regulate the translation of specific mRNAs by modulating the
phosphorylation of ribosomal protein S6. S6 phosphorylation plays an
important role in regulating the synthesis of ribosomal proteins and
elongation factors (eEF), which are encoded by mRNAs containing
terminal oligopyrimidine tracts at the 5'-end of the message (TOP
mRNAs) (reviewed by Jefferies and Thomas 1996
). In L6
myoblasts in culture, leucine enhances phosphorylation of S6K1 and
ribosomal protein S6 in association with increases in the synthesis of
eEF1A (Kimball et al. 1999
). The mechanism involved in
the translation of TOP mRNAs in association with ribosomal protein S6
phosphorylation is not known. However, in vitro studies employing
chemical cross-linking to investigate the structural arrangement
within the initiation complex reveal that S6 present in ribosomes is in
close proximity with both the eIFs and mRNA (Nygard and Nilsson 1990
). Therefore, phosphorylation of S6 could alter the
interaction of the protein with either of these components and promote
the translation of TOP mRNAs. The ability of leucine to promote the
hyperphosphorylation of both 4E-BP1 and S6K1 suggests a common
signaling pathway through which leucine upregulates protein synthesis
by enhancing both the activity and the synthesis of proteins involved
in mRNA translation.
Recent studies using cells in culture indicate that the
hyperphosphorylation of 4E-BP1 and S6K1 in the presence of amino acids,
particularly leucine, involves a signaling pathway that includes the
protein kinase referred to as mammalian target of rapamycin (mTOR)
(Kimball et al. 1999
, Patti et al. 1998
,
Xu et al. 1998
). To investigate the role of mTOR
signaling in the stimulation of translation initiation and protein
synthesis in vivo, food-deprived rats were injected intravenously
with the immunosuppressant drug rapamycin, a specific inhibitor of
mTOR, 2 h prior to leucine administration (Anthony et al. 2000b
). Rapamycin completely prevents the leucine-dependent
hyperphosphorylation of both 4E-BP1 and S6K1 (Table 1
). These results suggest that mTOR signaling is essential for the
leucine-dependent stimulation of translation initiation. However,
available evidence indicates that the stimulation of skeletal muscle
protein synthesis following leucine administration may involve
additional intracellular signaling pathways. Although rapamycin
attenuates rates of protein synthesis in rats administered leucine, the
drug also inhibits protein synthesis in food-deprived animals
(Table 1)
. Thus, leucine promotes a significant stimulation of protein
synthesis in rats fed rapamycin. These results suggest that signaling
through mTOR alone is not sufficient to explain the
leucine-dependent stimulation of muscle protein synthesis. This
conclusion is supported by additional studies demonstrating that oral
administration of isoleucine can also promote the hyperphosphorylation
of both 4E-BP1 and S6K1 without a concomitant increase in rates of
protein synthesis in skeletal muscle (Anthony et al. 2000b
). Alternate pathways activated by leucine that could
result in the stimulation of muscle protein synthesis are currently
under investigation.
|
| Upstream signaling events in the leucine-dependent stimulation of translation initiation |
|---|
|
|
|---|
An accumulating amount of evidence points to mTOR as a convergence
point for both amino acid and insulin-mediated effects on
translation initiation. Experiments in HEK-293 cells demonstrate
insulin treatment to induce phosphorylation of mTOR at Ser 2448, a site
that is considered crucial in the activation of the kinase (Nave et al. 1999
). On the other hand, amino acid starvation reduces
the phosphorylation of mTOR at the Ser 2448 residue and makes the
phosphorylation of this site refractory to insulin. Further, in an in
vitro kinase assay, activated PKB does not phosphorylate mTOR at Ser
2448 when mTOR is immunoprecipitated from amino aciddeprived cells
(Nave et al. 1999
). Interpretation of these results
leads to two possibilities: either amino acid deprivation activates a
phosphatase specific for mTOR at Ser 2448, or amino acids regulate a
kinase that can activate a "priming" phosphorylation site on mTOR
whose phosphorylation is a prerequisite for phosphorylation by PKB.
Currently, there is no evidence to directly support activation of a
phosphatase by amino acid withdrawal or data to show the existence of a
priming kinase.
A possible role for the protein kinase C (PKC) family of proteins in
regulating translation initiation by amino acids is beginning to
emerge. The PKC family is a group of at least 11 proteins that are
involved in the regulation of various cellular processes (Dekker et al. 1995
). Recent evidence has identified PKC
, classified
as a novel PKC, to be involved in the control of mTOR activation and
cap-dependent translation (Kumar et al. 2000
,
Parekh et al. 1999
). Studies in amino aciddeprived
HEK293 cells show that addition of amino acids to the culture medium
results in phosphorylation of the kinase at Ser 662, a site that is
associated with its maximal activation. This result can be reproduced
by adding back leucine alone (Parekh et al. 1999
).
Even though PKC
may be involved in leucine signaling to mTOR, it is
unlikely that PKC
is the initial "leucine signal." Several lines
of evidence support this conclusion (Kumar et al. 2000
).
First, whereas PKC
is found to be constitutively associated with
mTOR, PKC
does not directly phosphorylate mTOR. Second, activation
of mTOR is required for PKC
-mediated phosphorylation of 4E-BP1.
Finally, PKC
-mediated phosphorylation of 4E-BP1 is rapamycin
sensitive, and therefore not independent of mTOR. These lines of
evidence suggest that the activities of both mTOR and PKC
are
required for leucine-induced maximal phosphorylation of 4E-BP1.
Taking into account what is currently known from both in vivo and in
vitro studies, the following model can be proposed (Fig. 1)
.
Administration of leucine in vivo results in a transient release of
insulin and/or enhanced sensitivity of muscle cells to insulin.
Presentation of insulin at the muscle cell surface results in its
binding to the insulin receptor, which not only causes
autophosphorylation of the receptor and activation of the IRS proteins
but also thereby initiates the PI 3-K signaling cascade. Further,
leucine initiates a novel signaling cascade through some unidentified
mechanism that is independent of PI 3-K, PKB (Akt) or
3-phosphoinositide dependent protein kinase 1 (PDK1) activation. The
insulin signal and the leucine signal appear to converge at mTOR, where
both signals are required for maximal activation of the translation
initiation. This convergence may also require the activation of PKC
.
Further, other unidentified signaling molecules and/or pathways also
likely contribute, providing either a degree of redundancy or an
increased capability to fine-tune the response.
Several studies indicate that leucine functions as a nutritional signaling molecule that regulates protein synthesis in skeletal muscle following food intake. The stimulatory effect of leucine on protein synthesis occurs at the level of translation initiation and involves signaling through mTOR. However, signaling through mTOR alone is not sufficient to explain the increased rates of protein synthesis following leucine administration. Further studies are required to determine additional signaling pathways activated by leucine that regulate protein synthesis. It is likely that maximal rates of protein synthesis following food intake require both leucine and insulin signaling.
| FOOTNOTES |
|---|
3 Abbreviations used: BCAA, branched-chain
amino acid; eEF, eukaryotic elongation factor; eIF, eukaryotic
initiation factor; met-tRNAi, initiator methionyl-tRNA;
mTOR, mammalian target of rapamycin; PDK1,
3-phosphoinositidedependent protein kinase 1; PI 3-K, phosphoinositol
3-kinase; PKB, protein kinase B; PKC, protein kinase C; S6K1, 70-kDa
ribosomal protein S6 kinase; TOP, terminal oligopyrimidine; 4E-BP,
eukaryotic initiation factor 4E binding protein. ![]()
| REFERENCES |
|---|
|
|
|---|
1.
Anthony J. C., Gautsch Anthony T., Kimball S. R., Vary T. C., Jefferson L. S. Orally administered leucine stimulates protein synthesis in skeletal muscle of postabsorptive rats in association with increased eIF4F formation. J. Nutr. 2000a;130:139-145
2.
Anthony J. C., Gautsch Anthony T., Layman D. K. Leucine supplementation enhances skeletal muscle recovery in rats following exercise. J. Nutr. 1999;129:1102-1106
3.
Anthony J. C., Yoshizawa F., Gautsch Anthony T., Vary T. C., Jefferson L. S., Kimball S. R. Leucine stimulates translation initiation in skeletal muscle of post-absorptive rats via a rapamycin-sensitive pathway. J. Nutr. 2000b;130:2413-2419
4.
Burnett P. E., Barrow R. K., Cohen N. A., Snyder S. H., Sabatini D. M. Raft1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proc. Natl. Acad. Sci. U.S.A. 1998;95:1432-1437
5. Buse M. G., Atwell R., Mancusi V. In vitro effect of branched chain amino acids on the ribosomal cycle in muscles of fasted rats. Horm. Metab. Res. 1979;11:289-292[Medline]
6. Buse M. G., Reid S. S. Leucine: a possible regulator of protein turnover in muscle. J. Clin. Inv. 1975;56:1250-1261
7. Dekker L. V., Palmer R. H., Parker P. J. The protein kinase C and protein kinase C related families. Curr. Opin. Struct. Biol. 1995;5:396-402[Medline]
8.
Fulks R. M., Li J. B., Goldberg A. L. Effects of insulin, glucose, and amino acids on protein turnover in rat diaphragm. J. Biol. Chem. 1975;250:290-298
9. Funabiki R., Yagasaki K., Hara H., Nyumura N., Yoshizawa F., Saito K. In vivo effect of L-leucine administration on protein synthesis in mice. J. Nutr. Biochem. 1992;3:401-407
10. Garlick P. J., Fern M., Preedy V. R. The effect of insulin infusion and food intake on muscle protein synthesis in postabsorptive rats. Biochem. J. 1983;210:669-676[Medline]
11. Garlick P. J., Grant I. Amino acid infusion increases the sensitivity of muscle protein synthesis in vivo to insulin. Biochem. J. 1988;254:579-584[Medline]
12. Gautsch T. A., Anthony J. C., Kimball S. R., Paul G. L., Layman D. K., Jefferson L. S. Availability of eIF4E regulates skeletal muscle protein synthesis during recovery from exercise. Am. J. Physiol. Cell Physiol. 1998;43:C406-C414
13.
Hara K., Yonezawa K., Weng Q.-P., Kozlowski M. T., Belham C., Avruch J. Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. J. Biol. Chem. 1998;273:14484-14494
14. Hong S.-O.C., Layman D. K. Effects of leucine on in vitro protein synthesis and degradation in rat skeletal muscles. J. Nutr. 1984;114:1204-1212
15. Jefferies H.B.J., Thomas G. Ribosomal protein S6 phosphorylation and signal transduction. Hershey J.W.B. Mathews M. B. Sonenberg N. eds. Translational Control 1996:389-409 Cold Spring Harbor Laboratory Press Plainview, NY.
16. Kimball S. R., Jefferson L. S. Mechanisms of translational control in liver and skeletal muscle. Biochimie 1994;76:729-736[Medline]
17.
Kimball S. R., Shantz L. M., Horetsky R. L., Jefferson L. S. Leucine regulates translation of specific mRNAs in L6 myoblasts through mTOR-mediated changes in availability of eIF4E and phosphorylation of ribosomal protein S6. J. Biol. Chem. 1999;274:11647-11652
18.
Kumar V., Pandey P., Sabatini D., Kumar M., Majumder P. K., Bharti A., Carmichael G., Kufe D., Kharbanda S. Functional interaction between RAFT1/FRAP/mTOR and protein kinase C
in the regulation of cap-dependent initiation of translation. EMBO J 2000;19:1087-1097[Medline]
19. Li J. B., Jefferson L. S. Influence of amino acid availability on protein turnover in perfused skeletal muscle. Biochim. Biophys. Acta 1978;544:351-359[Medline]
20. Malaisse W. J. Branched chain amino and keto acids as regulators of insulin and glucagon release. Adibi S. A. Fekl W. Langenbeck U. Schauder P. eds. Branched Chain Amino and Keto Acids in Health and Disease 1984:119-133 Karger Basel, Switzerland.
21. McNurlan M. A., Fern E. B., Garlick P. J. Failure of leucine to stimulate protein synthesis in vivo. Biochem. J. 1982;204:831-838[Medline]
22. Nave B. T., Ouwens D. M., Withers D. J., Alessi D. R., Shepherd P. R. Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem. J. 1999;344:427-431
23. Nygard O., Nilsson L. Translational dynamics 1990 Interactions between the translational factors tRNA and ribosomes during eukaryotic protein synthesis. Eur. J. Biochem. 191 117.
24. Pain V. M. Initiation of protein synthesis in eukaryotic cells. Eur. J. Biochem. 1996;236:747-771[Medline]
25.
Parekh D., Ziegler W., Yonezawa K., Hara K., Parker P. Mammalian TOR controls one of two kinase pathways acting upon nPKC
and nPKC
. J. Biol. Chem. 1999;274:34758-34764
26. Patti M.-E., Brambilla E., Luzi L., Landaker E. J., Kahn C. R. Bidirectional modulation of insulin action by amino acids. J. Clin. Invest. 1998;101:1519-1529[Medline]
27. Pause A., Belsham G. J., Gingras A.-G., Donze O., Lin T.-A., Lawrence J. C., Jr, Sonenberg N. Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function. Nature (Lond.) 1994;371:762-767[Medline]
28.
Shah O. J., Anthony J. C., Kimball S. R., Jefferson L. S. Glucocorticoids oppose translational control by leucine in skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 2000;279:E1185-E1190
29. Svanberg E., Jefferson L. S., Lundholm K., Kimball S. R. Postprandial stimulation of muscle protein synthesis is independent of changes in insulin. Am. J. Physiol. Endocrinol. Metab. 1997;35:E841-E847
30. Voorma H. O., Thomas A.A.M., Van Heugten H.A.A. Initiation of protein synthesis in eukaryotes. Mol. Biol. Rep. 1994;19:139-145[Medline]
31.
Xu G., Kwon G., Marshall C. A., Lin T.-A., Lawrence J. C., Jr, McDaniel M. L. Branched-chain amino acids are essential in the regulation of PHAS-I and p70 S kinase by pancreatic ß-cells. J. Biol. Chem. 1998;273:28178-28184
32. Yoshizawa F., Endo M., Ide H., Yagasaki K., Funabiki R. Translational regulation of protein synthesis in the liver and skeletal muscle of mice in response to refeeding. J. Nutr. Biochem. 1995;6:130-136
33. Yoshizawa F., Kimball S. R., Jefferson L. S. Modulation of translation initiation in rat skeletal muscle and liver in response to food intake. Biochem. Biophys. Res. Commun. 1997;240:825-831[Medline]
34. Yoshizawa F., Kimball S. R., Vary T. C., Jefferson L. S. Effect of dietary protein on translation initiation in rat skeletal muscle and liver. Am. J. Physiol. Endocrinol. Metab. 1998;38:E814-E820
This article has been cited by other articles:
![]() |
L. J. C. van Loon, Y. Boirie, A. P. Gijsen, J. Fauquant, A. L. de Roos, A. K. Kies, S. Lemosquet, W. H. M. Saris, and R. Koopman The production of intrinsically labeled milk protein provides a functional tool for human nutrition research J Dairy Sci, October 1, 2009; 92(10): 4812 - 4822. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. G. Anthony and J. C. Anthony AMPing Down Leucine Action in Skeletal Muscle J. Nutr., December 1, 2008; 138(12): 2307 - 2308. [Full Text] [PDF] |
||||
![]() |
T. C. Vary Acute Oral Leucine Administration Stimulates Protein Synthesis during Chronic Sepsis through Enhanced Association of Eukaryotic Initiation Factor 4G with Eukaryotic Initiation Factor 4E in Rats J. Nutr., September 1, 2007; 137(9): 2074 - 2079. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Vary and C. J. Lynch Nutrient Signaling Components Controlling Protein Synthesis in Striated Muscle J. Nutr., August 1, 2007; 137(8): 1835 - 1843. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Koopman, B. Pennings, A. H. G. Zorenc, and L. J. C. van Loon Protein Ingestion Further Augments S6K1 Phosphorylation in Skeletal Muscle Following Resistance Type Exercise in Males J. Nutr., August 1, 2007; 137(8): 1880 - 1886. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Dorfman, B. D. Levine, T. Tillery, R. M. Peshock, J. L. Hastings, S. M. Schneider, B. R. Macias, G. Biolo, and A. R. Hargens Cardiac atrophy in women following bed rest J Appl Physiol, July 1, 2007; 103(1): 8 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, K. Guo, R. E. LeBlanc, D. Loh, G. J. Schwartz, and Y.-H. Yu Increasing Dietary Leucine Intake Reduces Diet-Induced Obesity and Improves Glucose and Cholesterol Metabolism in Mice via Multimechanisms Diabetes, June 1, 2007; 56(6): 1647 - 1654. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Du, Q. W. Shen, M. J. Zhu, and S. P. Ford Leucine stimulates mammalian target of rapamycin signaling in C2C12 myoblasts in part through inhibition of adenosine monophosphate-activated protein kinase J Anim Sci, April 1, 2007; 85(4): 919 - 927. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Engelen, E. P. Rutten, C. L. De Castro, E. F. Wouters, A. M. Schols, and N. E. Deutz Supplementation of soy protein with branched-chain amino acids alters protein metabolism in healthy elderly and even more in patients with chronic obstructive pulmonary disease Am. J. Clinical Nutrition, February 1, 2007; 85(2): 431 - 439. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Frost, G. J. Nystrom, L. S. Jefferson, and C. H. Lang Hormone, cytokine, and nutritional regulation of sepsis-induced increases in atrogin-1 and MuRF1 in skeletal muscle Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E501 - E512. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Lang, D. Huber, and R. A. Frost Burn-induced increase in atrogin-1 and MuRF-1 in skeletal muscle is glucocorticoid independent but downregulated by IGF-I Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R328 - R336. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lacroix, C. Bos, J. Leonil, G. Airinei, C. Luengo, S. Dare, R. Benamouzig, H. Fouillet, J. Fauquant, D. Tome, et al. Compared with casein or total milk protein, digestion of milk soluble proteins is too rapid to sustain the anabolic postprandial amino acid requirement. Am. J. Clinical Nutrition, November 1, 2006; 84(5): 1070 - 1079. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fujita, B. B. Rasmussen, J. G. Cadenas, J. J. Grady, and E. Volpi Effect of insulin on human skeletal muscle protein synthesis is modulated by insulin-induced changes in muscle blood flow and amino acid availability Am J Physiol Endocrinol Metab, October 1, 2006; 291(4): E745 - E754. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Lynch, B. Gern, C. Lloyd, S. M. Hutson, R. Eicher, and T. C. Vary Leucine in food mediates some of the postprandial rise in plasma leptin concentrations Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E621 - E630. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Wakshlag, F. A. Kallfelz, R. R. Wakshlag, and G. M. Davenport The Effects of Branched-Chain Amino Acids on Canine Neoplastic Cell Proliferation and Death J. Nutr., July 1, 2006; 136(7): 2007S - 2010S. [Full Text] [PDF] |
||||
![]() |
R. Koopman, A. H. G. Zorenc, R. J. J. Gransier, D. Cameron-Smith, and L. J. C. van Loon Increase in S6K1 phosphorylation in human skeletal muscle following resistance exercise occurs mainly in type II muscle fibers Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1245 - E1252. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Vary and C. J. Lynch Meal feeding enhances formation of eIF4F in skeletal muscle: role of increased eIF4E availability and eIF4G phosphorylation Am J Physiol Endocrinol Metab, April 1, 2006; 290(4): E631 - E642. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Norton and D. K. Layman Leucine Regulates Translation Initiation of Protein Synthesis in Skeletal Muscle after Exercise J. Nutr., February 1, 2006; 136(2): 533S - 537S. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kobayashi, H. Kato, Y. Hirabayashi, H. Murakami, and H. Suzuki Modulations of Muscle Protein Metabolism by Branched-Chain Amino Acids in Normal and Muscle-Atrophying Rats J. Nutr., January 1, 2006; 136(1): 234S - 236S. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Vary, S. Goodman, L. E. Kilpatrick, and C. J. Lynch Nutrient regulation of PKC{epsilon} is mediated by leucine, not insulin, in skeletal muscle Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E684 - E694. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Matthews Observations of Branched-Chain Amino Acid Administration in Humans J. Nutr., June 1, 2005; 135(6): 1580S - 1584S. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Paddon-Jones, M. Sheffield-Moore, A. Aarsland, R. R. Wolfe, and A. A. Ferrando Exogenous amino acids stimulate human muscle anabolism without interfering with the response to mixed meal ingestion Am J Physiol Endocrinol Metab, April 1, 2005; 288(4): E761 - E767. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. I. Baum, J. C. O'Connor, J. E. Seyler, T. G. Anthony, G. G. Freund, and D. K. Layman Leucine reduces the duration of insulin-induced PI 3-kinase activity in rat skeletal muscle Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E86 - E91. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Ventrucci, M A R Mello, and M C C Gomes-Marcondes Proteasome activity is altered in skeletal muscle tissue of tumour-bearing rats a leucine-rich diet Endocr. Relat. Cancer, December 1, 2004; 11(4): 887 - 895. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Layman Protein Quantity and Quality at Levels above the RDA Improves Adult Weight Loss J. Am. Coll. Nutr., December 1, 2004; 23(suppl_6): 631S - 636S. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Mothe-Satney, N. Gautier, C. Hinault, J. C. Lawrence Jr., and E. Van Obberghen In Rat Hepatocytes Glucagon Increases Mammalian Target of Rapamycin Phosphorylation on Serine 2448 but Antagonizes the Phosphorylation of Its Downstream Targets Induced by Insulin and Amino Acids J. Biol. Chem., October 8, 2004; 279(41): 42628 - 42637. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Broca, V. Breil, C. Cruciani-Guglielmacci, M. Manteghetti, C. Rouault, M. Derouet, S. Rizkalla, B. Pau, P. Petit, G. Ribes, et al. Insulinotropic agent ID-1101 (4-hydroxyisoleucine) activates insulin signaling in rat Am J Physiol Endocrinol Metab, September 1, 2004; 287(3): E463 - E471. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Liu, G. Li, S. R. Kimball, L. A. Jahn, and E. J. Barrett Glucocorticoids modulate amino acid-induced translation initiation in human skeletal muscle Am J Physiol Endocrinol Metab, August 1, 2004; 287(2): E275 - E281. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Layman and J. I. Baum Dietary Protein Impact on Glycemic Control during Weight Loss J. Nutr., April 1, 2004; 134(4): 968S - 973S. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.M.W.J. Schols Nutritional and metabolic modulation in chronic obstructive pulmonary disease management Eur. Respir. J., November 2, 2003; 22(46_suppl): 81s - 86s. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hashimoto and H. Hara Dietary Amino Acids Promote Pancreatic Protease Synthesis at the Translation Stage in Rats J. Nutr., October 1, 2003; 133(10): 3052 - 3057. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Lynch, B. Halle, H. Fujii, T. C. Vary, R. Wallin, Z. Damuni, and S. M. Hutson Potential role of leucine metabolism in the leucine-signaling pathway involving mTOR Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E854 - E863. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Blais, J.-F. Huneau, L. J. Magrum, T. J. Koehnle, J. W. Sharp, D. Tome, and D. W. Gietzen Threonine Deprivation Rapidly Activates the System A Amino Acid Transporter in Primary Cultures of Rat Neurons from the Essential Amino Acid Sensor in the Anterior Piriform Cortex J. Nutr., July 1, 2003; 133(7): 2156 - 2164. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Layman, H. Shiue, C. Sather, D. J. Erickson, and J. Baum Increased Dietary Protein Modifies Glucose and Insulin Homeostasis in Adult Women during Weight Loss J. Nutr., February 1, 2003; 133(2): 405 - 410. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Layman The Role of Leucine in Weight Loss Diets and Glucose Homeostasis J. Nutr., January 1, 2003; 133(1): 261S - 267. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. McDaniel, C. A. Marshall, K. L. Pappan, and G. Kwon Metabolic and Autocrine Regulation of the Mammalian Target of Rapamycin by Pancreatic {beta}-Cells Diabetes, October 1, 2002; 51(10): 2877 - 2885. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. Bergen Introduction J. Nutr., November 1, 2001; 131(11): 2976S - 2977. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||